Literature DB >> 17657216

The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide.

K Giannopoulos, M Schmitt, P Własiuk, J Chen, A Bojarska-Junak, M Kowal, J Roliñski, A Dmoszyñska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17657216     DOI： 10.1038/sj.leu.2404869

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  19 in total

1.  HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.

Authors:  Roberta Rizzo; Valentina Audrito; Paola Vacca; Davide Rossi; Davide Brusa; Marina Stignani; Daria Bortolotti; Giovanni D'Arena; Marta Coscia; Luca Laurenti; Francesco Forconi; Gianluca Gaidano; Maria Cristina Mingari; Lorenzo Moretta; Fabio Malavasi; Silvia Deaglio
Journal:  Haematologica       Date:  2013-12-20       Impact factor: 9.941

2.  Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Authors:  Paolo Giannoni; Gabriella Pietra; Giorgia Travaini; Rodolfo Quarto; Genti Shyti; Roberto Benelli; Laura Ottaggio; Maria Cristina Mingari; Simona Zupo; Giovanna Cutrona; Ivana Pierri; Enrico Balleari; Alessandra Pattarozzi; Marco Calvaruso; Claudio Tripodo; Manlio Ferrarini; Daniela de Totero
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

Review 3.  A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Authors:  Maurizio Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

4.  Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.

Authors:  K P Piper; M Karanth; A McLarnon; E Kalk; N Khan; J Murray; G Pratt; P A H Moss
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

5.  Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia.

Authors:  Angélique Biancotto; Pradeep K Dagur; John C Fuchs; Adrian Wiestner; C Bruce Bagwell; J Philip McCoy
Journal:  Mod Pathol       Date:  2011-11-18       Impact factor: 7.842

6.  Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia.

Authors:  Bang-Ning Lee; Hui Gao; Evan N Cohen; Xavier Badoux; William G Wierda; Zeev Estrov; Stefan H Faderl; Michael J Keating; Alessandra Ferrajoli; James M Reuben
Journal:  Cancer       Date:  2011-02-24       Impact factor: 6.860

Review 7.  Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions.

Authors:  Farhad Jadidi-Niaragh; Ghasem Ghalamfarsa; Mehdi Yousefi; Mina Hajifaraj Tabrizi; Fazel Shokri
Journal:  Tumour Biol       Date:  2013-05-17

8.  Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.

Authors:  Farhad Jadidi-Niaragh; Ghasem Ghalamfarsa; Ali Memarian; Hossein Asgarian-Omran; Seyed Mohsen Razavi; Abdolfattah Sarrafnejad; Fazel Shokri
Journal:  Tumour Biol       Date:  2012-12-27

9.  Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.

Authors:  Sanda Alexandrescu; Nina Tatevian; Bogdan A Czerniak; Michael H Covinsky; Nadja K Burns; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29

Review 10.  The targeting of immunosuppressive mechanisms in hematological malignancies.

Authors:  M H Andersen
Journal:  Leukemia       Date:  2014-03-18       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.